Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Asset Utilization Ratio (2016 - 2026)

Myriad Genetics has reported Asset Utilization Ratio over the past 15 years, most recently at 1.15 for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 44.69% to 1.15 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.15 through Dec 2025, up 44.69% year-over-year, with the annual reading at 0.95 for FY2025, 23.41% up from the prior year.
  • Asset Utilization Ratio was 1.15 for Q4 2025 at Myriad Genetics, down from 1.17 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.17 in Q3 2025 and troughed at 0.52 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.62 (2023), against an average of 0.7.
  • Year-over-year, Asset Utilization Ratio decreased 11.26% in 2022 and then soared 54.47% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.52 in 2021, then grew by 8.25% to 0.56 in 2022, then increased by 16.59% to 0.66 in 2023, then rose by 21.05% to 0.79 in 2024, then soared by 44.69% to 1.15 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Asset Utilization Ratio are 1.15 (Q4 2025), 1.17 (Q3 2025), and 0.99 (Q2 2025).